By naming their company Haven, leaders of the health venture formed by Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. sought to create a brand unlike anything else in American medicine — a business uniquely capable of sheltering customers from insurance hassles and unreasonable costs.

There’s just one hitch: Dozens of other companies already use the same name, including a large handful that deliver or facilitate health services, according to a review of registrations on file with the U.S. Patent and Trademark Office.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy